Latest News
- January 29, 2008
Codexis Launches Codex™ Microcyp Platform To Produce Drug Metabolites And Novel Lead Compounds - January 17, 2008
Codexis Names Nicholas Green President, Codexis Pharmaceuticals - October 25, 2007
Codexis Opens Singapore Laboratory - October 1, 2007
Codexis Announces Four New Codex™ Biocatalyst Panels
Codexis Pharmaceuticals serves global leaders in the innovator and generics sectors of the pharmaceutical industry worldwide.
Codexis partners with many of the world's leading drug manufacturers to provide custom biocatalysts and services that improve manufacturing productivity. The company also provides cost-effective pharmaceutical intermediates to the world's rapidly-growing generics industry.
Codexis technology enables pharmaceutical manufacturers to harness the power of biocatalysts to increase R&D and manufacturing productivity while significantly reducing cost. Custom biocatalysts can accelerate production of active pharmaceutical ingredients and intermediates needed to produce new human therapeutics, leading to faster, earlier development of efficient, lower-cost and environmentally sound manufacturing processes.
Codexis technology enables pharmaceutical manufacturers to harness the power of biocatalysts to increase R&D and manufacturing productivity while significantly reducing cost.